Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-284854
Filing Date
2015-08-10
Accepted
2015-08-10 16:09:14
Documents
13
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d16402d10q.htm 10-Q 621089
2 EX-10.1 d16402dex101.htm EX-10.1 19850
3 EX-10.2 d16402dex102.htm EX-10.2 33783
4 EX-31.1 d16402dex311.htm EX-31.1 8111
5 EX-31.2 d16402dex312.htm EX-31.2 8097
6 EX-32.1 d16402dex321.htm EX-32.1 4203
13 GRAPHIC g16402g91a63.gif GRAPHIC 58927
  Complete submission text file 0001193125-15-284854.txt   3594356

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT enta-20150630.xml EX-101.INS 536892
8 XBRL TAXONOMY EXTENSION SCHEMA enta-20150630.xsd EX-101.SCH 37708
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20150630_cal.xml EX-101.CAL 64372
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20150630_def.xml EX-101.DEF 162743
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20150630_lab.xml EX-101.LAB 344060
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20150630_pre.xml EX-101.PRE 258866
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 151040832
SIC: 2834 Pharmaceutical Preparations